An expert on the intersection of HIV and menopause, Bridgette J. Picou, LVN, ACLPN, The Well Project, explains the importance ...

The PROMISE-US study, presented at the 2025 Conference on Retroviruses and Opportunistic Infections, showed that ibalizumab-containing regimens achieved similar rates of viral suppression compared ...

After attending the Conference on Retroviruses and Opportunistic Infections 2025 in San Francisco, Jean-Michel Molina, MD, PhD, head of the Infectious Diseases Department at the Saint-Louis ...

The study’s lead author, Professor Neel Gandhi of Emory University in Atlanta, recently presented the findings at the Conference on Retroviruses and Opportunistic Infections in San Francisco. The work ...

The study's lead author, Professor Neel Gandhi of Emory University in Atlanta, recently presented the findings at the Conference on Retroviruses and Opportunistic Infections (CROI) in San Francisco.

The study's lead author, Professor Neel Gandhi of Emory University in Atlanta, recently presented the findings at the Conference on Retroviruses and Opportunistic Infections (CROI) in San Francisco.

The trial, presented at the 2025 Conference on Retroviruses and Opportunistic Infections (CROI) in San Francisco, marks a major milestone in HIV cure research. It stands out not only for its ...

Hayden, MD, professor of medicine and pathology in the University of Virginia School of Medicine, said during a presentation at the Conference on Retroviruses and Opportunistic Infections.

Imperial College London and the University of Oxford (RIO)—was recently presented at the Conference on Retroviruses and Opportunistic Infections (CROI 2025), held in San Francisco March 9–12.